Featured Posts
ATR Submits Comments Urging USITC to Recommend Against TRIPS Waiver Expansion
Last week, Americans for Tax Reform and the Property Rights Alliance submitted respective comments to the United States International Trade Commission (USITC) urging the agency…
Commentary
ATR Joins Coalition in Support of Site-Neutral Payments
Today, Americans for Tax Reform joined a coalition letter in support of site-neutral payments and service billing transparency in commercial health insurance. The letter,…
Commentary
S.127 Would Increase the Deficit by Tens of Billions of Dollars
Today, the Senate Commerce Committee will hold an executive session considering S. 127, the Pharmacy Benefit Manager Transparency Act (PBMTA), legislation that was recently re-introduced by…
Commentary
Filtered Posts
Biden Budget Expands Disastrous Price Controls on Medicine
Commentary
Sen. Cruz is Right to Urge Caution on Giving FTC New Power to Regulate
Commentary
Senate Should Reject S. 150, Legislation That Would Stunt Medical Innovation
Commentary
Even Before Implementation, Democrats’ Price Control Policies are Inhibiting Medical Innovation
Commentary
ATR Supports Senator Lee’s Bill to Roll Back Biden’s Drug Price Controls
Commentary
Poll: Canadians Significantly Less Confident in Their Healthcare System Than Americans
Commentary
STUDY: Drug Price Controls Will Actually Raise Health Costs
Commentary
Drug Price Controls Will Cost Lives, Not Save Them
Commentary
Biden Isn’t “Negotiating” Drug Prices, He’s Forcing Price Controls Through Tax Hikes
Commentary
Expanding Obamacare Subsidies Will Make Inflation Worse
Commentary